RxDoctor Payments Data

George Cotsarelis, MD

Dermatology · Philadelphia, PANPI 1871540831

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,500 of the $6,694 with a category attached, or 67.2%. Pfizer accounts for 68.1% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $4,500 and has fallen 99.2% since, to $37 in 2023.

$6,694in general payments, 2019–2025

Across 6 payments — averaging $1115.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$5K
  • GSK$2K
  • AbbVie$27
$185,000in research payments, 2019–2025

Across 2 payments — averaging $92,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$185K

What the payments were for

  • Consulting fees$2,10932%
  • Speaking & faculty fees$4,50067%
  • Food & beverage$851%

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer4$4,558
GSK1$2,109
AbbVie1$27

How this compares

$6,694 in reported general payments places this provider in the 75th percentile of 626 dermatology providers in Pennsylvania.

See all dermatology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$9,299
Medicare patients
51
Services billed
152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydroxychloroquine Sulfate22$1,017
Minoxidil69$996
Clobetasol Propionate22$883
Finasteride32$406

Paid to pharmacies, not to this prescriber.

Other dermatology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →